Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 9:2:1006506.
doi: 10.3389/fneph.2022.1006506. eCollection 2022.

Mechanisms underlying acupuncture therapy in chronic kidney disease: A narrative overview of preclinical studies and clinical trials

Affiliations
Review

Mechanisms underlying acupuncture therapy in chronic kidney disease: A narrative overview of preclinical studies and clinical trials

Xinyin Liu et al. Front Nephrol. .

Abstract

Chronic kidney disease (CKD) is associated with high incidence, low awareness, and high disability rates among the population. Moreover, the disease significantly affects the physical and mental health of patients. Approximately 25% of patients with CKD develop end-stage renal disease (ESRD) within 20 years of diagnosis and have to rely on renal replacement therapy, which is associated with high mortality, heavy economic burden, and symptoms including fatigue, pain, insomnia, uremia pruritus, and restless leg syndrome. Currently, the means to delay the progress of CKD are insufficient; therefore, developing strategies for delaying CKD progression has important practical implications. In recent years, more and more people are accepting the traditional Chinese medical technique "acupuncture." Acupuncture has been shown to improve the uncomfortable symptoms of various diseases through stimulation (needling, medicinal moxibustion, infrared radiation, and acupressure) of acupoints. Its application has been known for thousands of years, and its safety and efficacy have been verified. As a convenient and inexpensive complementary therapy for CKD, acupuncture has recently been gaining interest among clinicians and scientists. Nevertheless, although clinical trials and meta-analysis findings have demonstrated the efficacy of acupuncture in reducing albuminuria, improving glomerular filtration rate, relieving symptoms, and improving the quality of life of patients with CKD, the underlying mechanisms involved are still not completely understood. Few studies explored the correlation between acupuncture and renal pathological diagnosis. The aim of this study was to conduct a literature review summarizing the currently known mechanisms by which acupuncture could delay the progress of CKD and improve symptoms in patients with ESRD. This review help provide a theoretical basis for further research regarding the influence of acupuncture on renal pathology in patients with CKD, as well as the differences between specific therapeutic mechanisms of acupuncture in different renal pathological diagnosis. The evidence in this review indicates that acupuncture may produce marked effects on blocking and reversing the critical risk factors of CKD progression (e.g., hyperglycemia, hypertension, hyperlipidemia, obesity, aging, and anemia) to improve the survival of patients with CKD via mechanisms including oxidative stress inhibition, reducing inflammatory effects, improving hemodynamics, maintaining podocyte structure, and increasing energy metabolism.

Keywords: acupuncture; chronic kidney disease; complementary therapy; end-stage renal disease; therapeutic mechanism.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Mechanisms Underlying the Effects of Acupuncture Therapy in Chronic Kidney Disease. The gray grids are the known possible main mechanism/target/downstream product of acupuncture in treating chronic kidney disease. EPO, erythropoietin; GABA, γ-aminobutyric acid; SNS, sympathetic nervous system; PGC, proliferator γ coactivator; SNGFR, single nephron glomerular filtration rate; ET-1, endothelin-1; Ang II, angiotensin II; FSGS, focal segmental glomerulosclerosis; TIF, tubulointerstitial fibrosis; MDA, malondialdehyde; RCT, reverse cholesterol transport; CHOL, cholesterol; NF-κb, nuclear factor-kappa B; ROS, reactive oxygen species.

Similar articles

Cited by

References

    1. Group IGOCW . KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl (2013) 3:1–150. doi: 10.7326/0003-4819-158-11-201306040-00007 - DOI - PubMed
    1. Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, et al. . Prevalence of chronic kidney disease in China: A cross-sectional survey. Lancet (2012) 379:815–22. doi: 10.1016/S0140-6736(12)60033-6 - DOI - PubMed
    1. GBD 2019 Viewpoint Collaborators . Five insights from the global burden of disease study 2019. Lancet (2020) 396:1135–59. doi: 10.1016/S0140-6736(20)31404-5 - DOI - PMC - PubMed
    1. Appel GB, Waldman M. The IgA nephropathy treatment dilemma. Kidney Int (2006) 69:1939–44. doi: 10.1038/sj.ki.5000434 - DOI - PubMed
    1. Rovin BH, Adler SG, Barratt J, Bridoux F, Burdge KA, Chan TM, et al. . Kdigo 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int (2021) 100(4):S1–S276. doi: 10.1016/j.kint.2021.05.021 - DOI - PubMed